Phase 2 Maximum Tolerated Dose determined in Phase 1
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for anemia, refractory, with excess of blasts | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for congenital bone marrow failure syndromes | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for hemoglobinopathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for immunologic deficiency syndromes | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for metabolism, inborn errors | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |